VE-201 : Drug repurposing against vertigo and imbalances.
Generic drug compound VE-201 has been marketed for years for another clinical indication. It is now being repurposed by Vertidiag to treat vertigos and imbalances.
This compound has shown significant reduction of vestibular deficits in rodent models of acute vestibular disorders (article in preparation). In vivo results suggest that receptors of a hormone family could be a new therapeutic target to treat many forms of vestibular disorders.